Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro
- 31 July 1988
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 58 (2-3) , 213-219
- https://doi.org/10.1016/0303-7207(88)90157-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamideThe Prostate, 1987
- Plasma levels of steroid glucuronides in prepubertal, adult and elderly menJournal of Steroid Biochemistry, 1986
- Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancerJournal of Steroid Biochemistry, 1986
- A wide range of sensitivities to androgens develops in cloned shionogi mouse mammary tumor cellsThe Prostate, 1986
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985
- Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.BMJ, 1985
- The role of receptors in the steroidal regulation of tumour cell proliferationJournal of Steroid Biochemistry, 1976
- Two sex steroid receptors in SC-115 mammary tumor cellsExperimental Cell Research, 1976
- Adrenal Suppression in the Treatment of Carcinoma of the ProstateBritish Journal of Urology, 1974
- Extension of Multiple Range Tests to Group Means with Unequal Numbers of ReplicationsPublished by JSTOR ,1956